Literature DB >> 15932284

Large-scale expansion of mammary epithelial stem cell aggregates in suspension bioreactors.

Benjamin S Youn1, Arindom Sen, Michael S Kallos, Leo A Behie, Adele Girgis-Gabardo, Natasza Kurpios, Maria Barcelon, John A Hassell.   

Abstract

Mutations in the pathways regulating mammary epithelial stem cell (MESC) self-renewal and differentiation are currently hypothesized to result in uncontrolled cell division and, in turn, breast tumor formation. Although research is aggressively being pursued to understand how such pathways result in breast cancer formation, current studies have been greatly limited by MESC scarcity. To address this issue, this study has successfully developed large-scale expansion protocols for MESC through the subculture of murine mammary epithelial tissue aggregates, called mammospheres, in suspension bioreactors. Growth kinetics of mammospheres cultured in 125 mL suspension bioreactors and T-flasks were found to be comparable, achieving cell densities of 3.10 x 10(5) and 2.75 x 10(5) cells/mL, respectively. This corresponded to a 4-fold expansion over 8 days. Yields were also found to be strongly affected by liquid shear forces, where high agitation rates reduced overall cell numbers. Bioreactor cultures were scaled up to 1000 mL operating volumes, resulting in the production of 4.21 x 10(8) total cells (5.6-fold expansion) from a single passage. Furthermore, intermittent replacement of culture medium with fresh medium dramatically improved maximum cell densities, resulting in an 11-fold expansion, thereby enabling the generation of stem cells in quantities sufficient for standard biochemical and genetic analyses. After being cultured in suspension bioreactors for several passages, analysis by flow cytometry of Ki-67 revealed that 85% of the population was composed of proliferating cells. The successful development of expansion protocols for MESC aggregates in suspension bioreactors makes available experimental avenues that were not previously accessible for breast cancer research, thereby facilitating future investigations into elucidating the role of MESCs in breast cancer tumorigenesis.

Entities:  

Mesh:

Year:  2005        PMID: 15932284     DOI: 10.1021/bp050059f

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  6 in total

1.  Expansion of mouse sertoli cells on microcarriers.

Authors:  B Shi; S Zhang; Y Wang; Y Zhuang; J Chu; S Zhang; X Shi; J Bi; M Guo
Journal:  Cell Prolif       Date:  2010-06       Impact factor: 6.831

2.  Cancer stem/progenitor cell active compound 8-quinolinol in combination with paclitaxel achieves an improved cure of breast cancer in the mouse model.

Authors:  Jiangbing Zhou; Hao Zhang; Peihua Gu; Joseph B Margolick; Deling Yin; Ying Zhang
Journal:  Breast Cancer Res Treat       Date:  2008-05-28       Impact factor: 4.872

Review 3.  Bioreactor development for stem cell expansion and controlled differentiation.

Authors:  James A King; William M Miller
Journal:  Curr Opin Chem Biol       Date:  2007-07-25       Impact factor: 8.822

4.  Six1 expands the mouse mammary epithelial stem/progenitor cell pool and induces mammary tumors that undergo epithelial-mesenchymal transition.

Authors:  Erica L McCoy; Ritsuko Iwanaga; Paul Jedlicka; Nee-Shamo Abbey; Lewis A Chodosh; Karen A Heichman; Alana L Welm; Heide L Ford
Journal:  J Clin Invest       Date:  2009-08-24       Impact factor: 14.808

Review 5.  The Role of Serotonin in Breast Cancer Stem Cells.

Authors:  William D Gwynne; Mirza S Shakeel; Adele Girgis-Gabardo; John A Hassell
Journal:  Molecules       Date:  2021-05-26       Impact factor: 4.411

6.  Cell Culture Process Scale-Up Challenges for Commercial-Scale Manufacturing of Allogeneic Pluripotent Stem Cell Products.

Authors:  Brian Lee; Sunghoon Jung; Yas Hashimura; Maximilian Lee; Breanna S Borys; Tiffany Dang; Michael S Kallos; Carlos A V Rodrigues; Teresa P Silva; Joaquim M S Cabral
Journal:  Bioengineering (Basel)       Date:  2022-02-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.